Cholecystokinin-8
CCK-8 is the eight-amino acid bioactive fragment of cholecystokinin responsible for satiety signaling, pancreatic enzyme secretion, and gallbladder contraction.
Cholecystokinin-8
Biosynthesis and Processing
Cholecystokinin is synthesized as a preprohormone of 115 amino acids in enteroendocrine I cells of the duodenum and jejunum, as well as in select neuronal populations of the central nervous system. Prohormone convertases cleave the precursor to yield multiple bioactive forms, including CCK-58, CCK-33, CCK-22, and the octapeptide CCK-8. The C-terminal octapeptide (Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2) retains full biological activity and is the predominant form in the brain. Sulfation of Tyr7 produces CCK-8(S), while the unsulfated form is CCK-8(U), each exhibiting differential receptor selectivity.
Receptor Pharmacology
CCK-8 acts through two G protein-coupled receptors: CCK-A (CCK1) and CCK-B (CCK2). CCK-A receptors, expressed in the gastrointestinal tract and select brain regions, exhibit nanomolar affinity for sulfated CCK-8 and mediate peripheral physiological actions. CCK-B receptors, predominant in the central nervous system, display equal affinity for both sulfated and unsulfated CCK-8 as well as gastrin, reflecting the high sequence homology between CCK and gastrin in their shared C-terminal pentapeptide. Both receptors couple to Gq/11, activating phospholipase C and mobilizing intracellular calcium.
Satiety and Appetite Regulation
CCK-8 functions as a short-term satiety signal released in response to dietary protein and fat. Postprandial CCK release activates vagal afferent fibers expressing CCK-A receptors, transmitting satiety information to the nucleus tractus solitarius in the brainstem. Exogenous CCK-8 administration reduces meal size and duration in both animal models and human studies. However, chronic CCK-8 treatment produces tachyphylaxis, indicating that CCK functions as a meal-termination signal rather than a long-term adiposity regulator.
Pancreatic and Biliary Functions
CCK-8 stimulates pancreatic acinar cell enzyme secretion through both direct receptor activation and potentiation of cholinergic signaling. The peptide also induces gallbladder smooth muscle contraction and relaxation of the sphincter of Oddi, facilitating bile flow into the duodenum. These actions coordinate digestive enzyme and bile delivery to optimize nutrient absorption.
Central Nervous System Actions
In the brain, CCK-8 co-localizes with dopamine in mesolimbic pathways and modulates anxiety, pain, and memory. CCK-4 (the tetrapeptide fragment) is a panicogenic agent used in diagnostic provocation tests for panic disorder. CCK-B receptor antagonists have been investigated as anxiolytic agents, though clinical results have been mixed.
References
- Mutt V, Jorpes JE. Structure of porcine cholecystokinin-pancreozymin. European Journal of Biochemistry. 1968;15:513-519.
- Wank SA. Cholecystokinin receptors. American Journal of Physiology. 1995;269:G628-G646.
- Moran TH, Schwartz GJ. Biological specificity of gut-brain peptide signals. Behavioral Neuroscience. 1994;108:4-18.
Test Your Knowledge
Reinforce what you learned about Cholecystokinin-8 with interactive quizzes on Wikipept.
Take a Quiz on Wikipept